Professional Documents
Culture Documents
CALCIUM
PTH
- Secretion of PTH that is stimulated by a decreased in ionized Ca (thus, PTH
secretion is stopped by increase ionized Ca)
- PTH exerts 3 major effects on both BONE and KIDNEY
- In Bones:
o PTH activates a process known as BONE RESORPTION
o Activated osteoclasts break down bone and subsequently release Calcium
into the ECF.
- In Kidneys:
o PTH conserves calcium by increasing tubular reabsorption of calcium
ions. PTH also stimulates renal production of vitamin D.
Vitamin D
- It is a cholecalciferol
- Obtained from diet or exposure of skin to sunlight
- Vitamin D3 converted in the liver to 25-hydroxycholecalciferol (inactive form of
vit D) in the kidney, 25-OH-D3 is hydroxylated to form 1,25-
hydroxycholecalciferol (the biologically active form)
- Active form of vit D increases the calcium absorption in the intestine and
enhances the effect of PTH on bone resorption.
Calcitonin
- Originates in the medullary cells of the thyroid gland.
- Secreted when the concentration of calcium in blood increases.
- Inhibits the actions of both PTH and Vit D.
- It is secreted in response to hypercalcemic stimulus.
DISTRIBUTION
- 99% of Calcium is part of the bones
- 1% blood and ECF
- Ionized calcium in blood is greater than in the cytosol of cardiac or smooth
muscle cells in order to maintain rapid inward flux of calcium.
- In blood:
o 45% circulates as free calcium
o 40% is bound to protein (albumin)
o 15% is bound to anions
MBCL/2014
CC2/LAO/2013-2014 ELECTROLYTES 2
HYPOCALCEMIA
MBCL/2014
CC2/LAO/2013-2014 ELECTROLYTES 3
II. Treatment
a. Oral or parenteral calcium therapy
b. Administration of vitamin D
c. If hypomagnesemia is concurrent
a. Magnesium therapy should also be provided
Hypercalcemia
- Primary hyperparathyroidism
o Main cause of hypercalcemia
- Hyperparathyroidism
o Excess secretion of PTH
o Common among older woman
- Malignancies
o Second leading of cause of hypercalcemia
o May releases PTH-relate peptide
Which binds to normal PTH receptors and causes increased
calcium levels
- Hyperthyroidism may sometimes cause hyperparathyroidism
- Familial hypicalciuria
- Thaizied diuretics
o Increase calcium reabsorptions
Hypercalcemia
MBCL/2014
CC2/LAO/2013-2014 ELECTROLYTES 4
ii. Weakness
iii. Depression
iv. Lethargy
v. Coma
d. GI
i. Constipation
ii. Nausea
iii. Vomiting
iv. Anorexia
v. Peptic ulcer
e. Renal symptoms due to renal nephrolithiasis and nephrocalcinosis
f. Hypercalciuria can result in nephrogenic diabetis insipidus
i. Polyuria
ii. Hypovolemia
iii. Aggravates the hypercalcemia
g. Symptoms of digitalis toxicity
II. Treatment
a. Estrogen replacement for hypercalcemia among older woman
b. Parathyroidectomy among hyperparathyroidism
c. Salt and water intake to increase calcium excretion
DETERMINATION
Specimen
- Serum or lithium heparin plasma
- Samples must be collected anaerobically (loss of CO2 will increase the pH)
- Times urine concentration + 6 mol/L HCl 1 mL per 100 mL of urine
Methods
- 2 common methods
o Ortho-cresolphthalein complexone (CPC)
Arseno III dye to for a complex with calcium
Calcium is released from its protein carrier
Complexes by acidification of the sample
o ISEs
REFERENCE VALUES
Serum/Plasma
- Child < 12 years 2.20 – 2.70 mmol/L (8.8-10.8 mg/dL)
- Adult 2.15 - 2.50 mmol/L (8.6 – 10 mg/dL)
MBCL/2014
CC2/LAO/2013-2014 ELECTROLYTES 5
MBCL/2014